MX 2 is a novel regulator of cell cycle in melanoma cells
Marina Juraleviciute(Oslo University Hospital), Ana Slipicevic(Norwegian Cancer Society), Jérémie Nsengimana(University of Leeds), Meenhard Herlyn(The Wistar Institute), Viví Ann Flørenes(Oslo University Hospital), Assia Bassarova(Oslo University Hospital), Joanna Poźniak(VIB-KU Leuven Center for Cancer Biology), Mark Harland(Cancer Research UK), Juliette A. Randerson‐Moor(University of Leeds), Geir Frode Øy(Oslo University Hospital), Julia Newton‐Bishop(University of Leeds), Gunhild Trøen(Oslo University Hospital), D. Timothy Bishop(University of Leeds), Patrik Wernhoff(Oslo University Hospital)
Cited by 14
Related Papers
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Colorectal carcinoma antigens detected by hybridoma antibodies
|Somatic Cell and Molecular Genetics|1979|1.4k
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
|Cancer Research|2005|1.3k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996